Henry Schein, Inc. (HSIC) is currently trading at $73.11 with a trailing P/E of 23.06 and a forward P/E of 13.95 as of December 1st. Despite being the largest dental distributor in the U.S., HSIC’s stock is undervalued due to stagnant growth and margin performance, but potential catalysts like a new CEO could drive renewed growth.

With opportunities like private-label expansion and AI-driven growth, along with ongoing share repurchases, HSIC has the potential to reach an EPS of over $7 within two to three years. This could lead to the stock trading at under 10x earnings, making it an attractive investment for those seeking defensive industry exposure and upside potential.

While Henry Schein, Inc. may not be among the top 30 most popular stocks among hedge funds, it still presents a solid investment opportunity. However, there are AI stocks with even greater upside potential and less downside risk. For investors interested in AI stocks with significant growth potential under the current economic climate, there are alternatives worth considering.

Read more at Yahoo Finance: Henry Schein, Inc. (HSIC): A Bull Case Theory